January 6, 2010 The Nebraska Department of Health and Human Services started implementing a Medicaid Preferred Drug List (PDL) in October 2009 as required by the state's 2008 Medicaid Prescription Drug Act. The state seeks to increase utilization of less costly medications for Medicaid beneficiaries. A Pharmaceutical and Therapeutics (P&T) Committee was formed; at the first meetings, which took place in August and September 2009, the committee members voted on preferred or non-preferred status for 34 drug classes. Only drugs that are part of the listed therapeutic categories are affected by the PDL. Antidepressants, antipsychotics, and . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.